<p>Percentage of patients reporting side-effects on each day of treatment with sodium stibogluconate (SbV).</p
The prevalence of side effects among participants in terms of demographic characteristics after firs...
This descriptive cross-sectional study was carried out in the Department of Medicine, Rajshahi Medic...
<p>Overview of numbers and percentages of mild, moderate, and severe adverse events according to rel...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
are treated with parenteral sodium stibogluconate (SbV) to reduce the risk of development of mucocu...
<p>The group median (squares) fell significantly from its baseline by the first subsequent measureme...
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
WHAT IS KNOWN AND OBJECTIVE: Intravenous sodium stibogluconate (SbV) is the mainstay of treatment fo...
<p>The group median (squares) fell significantly from its baseline by the first subsequent measureme...
<p>Percentage of patients untreated versus treated, and distribution of antiviral HBV therapies.</p
Background: Patients with New World cutaneous leishmaniasis (NWCL) caused by Leishmania Viannia are ...
<p>Most common treatment-related adverse events reported in ≥10% of patients.</p
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
<p>Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours ...
The prevalence of side effects among participants in terms of demographic characteristics after firs...
The prevalence of side effects among participants in terms of demographic characteristics after firs...
This descriptive cross-sectional study was carried out in the Department of Medicine, Rajshahi Medic...
<p>Overview of numbers and percentages of mild, moderate, and severe adverse events according to rel...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
are treated with parenteral sodium stibogluconate (SbV) to reduce the risk of development of mucocu...
<p>The group median (squares) fell significantly from its baseline by the first subsequent measureme...
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
WHAT IS KNOWN AND OBJECTIVE: Intravenous sodium stibogluconate (SbV) is the mainstay of treatment fo...
<p>The group median (squares) fell significantly from its baseline by the first subsequent measureme...
<p>Percentage of patients untreated versus treated, and distribution of antiviral HBV therapies.</p
Background: Patients with New World cutaneous leishmaniasis (NWCL) caused by Leishmania Viannia are ...
<p>Most common treatment-related adverse events reported in ≥10% of patients.</p
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
<p>Comparison of the treatment side effects among sodium valproate and dexamethasone groups 2 hours ...
The prevalence of side effects among participants in terms of demographic characteristics after firs...
The prevalence of side effects among participants in terms of demographic characteristics after firs...
This descriptive cross-sectional study was carried out in the Department of Medicine, Rajshahi Medic...
<p>Overview of numbers and percentages of mild, moderate, and severe adverse events according to rel...
DOI
Add to ORKG